Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease.

Chin Med J (Engl) · 2023 · PMC10106168 · PMID 36914945

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

There are also lipid peroxidation biomarkers that are worth considering as useful biomarkers for progressive AD, such as dihomo-isoprostanes (17-epi-17-F2t-dihomo-IsoP, 17-F2t-dihomo-IsoP, Ent-7[RS]-7-F2t-dihomo-IsoP), and neuroprostheses (10-epi-10-F4t-NeuroP), which had very high probabilities of exhibiting an increasing trend over time.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.